{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:47:36Z","timestamp":1794293256740,"version":"4.9.0"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Gestational diabetes (GDM) is not only associated with markedly increased type 2 diabetes risk but is also associated with increased type 1 diabetes risk in later life. The aim of this work was to systematically evaluate the prevalence and clinical relevance of islet autoantibodies in patients with gestational diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A systematic literature search of the predefined keywords \u201cgestational diabetes\u201d or \u201cpregnancy diabetes\u201d and \u201cautoantibodies\u201d in the electronic databases PubMed, ScienceDirect, and ResearchGate from the beginning of the database until November 30, 2025 was performed. The selection of publications was based on the review of studies using predefined inclusion and exclusion criteria. The extracted data obtained were analyzed using meta-analytical techniques.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-one studies including a total of 7760 patients with gestational diabetes were included. Heterogeneity among the analyzed studies was high. The overall prevalence of islet autoantibodies was 10.6% (95% CI 8,2\u201313,0%) (I\n                      <jats:sup>2<\/jats:sup>\n                      \u00a0=\u00a095,9%) in patients with gestational diabetes, which was more than seven-fold higher than in pregnant women without gestational diabetes. Prevalence was highest for ICA and anti-GAD autoantibodies. The prevalence of islet autoantibodies decreased from 10.6% during pregnancy to 3.6% in the postpartum period (95% CI 2.1\u20135.1%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our data show a high prevalence of islet autoantibody positivity in patients with gestational diabetes suggesting a relevant pathophysiological role of autoimmunity in a subgroup of affected patients. These data underline the need of postpartum analysis of the autoantibody status and regular follow-up checks in patients with persistent islet autoantibody positivity. Heterogeneity among analyzed studies was high underlining the need of further prospective studies to more clearly define the role of islet autoantibodies in patients with gestational diabetes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1874930","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T04:25:25Z","timestamp":1785990325000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Islet-autoantibodies in gestational diabetes and risk of progression to postpartum diabetes: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Arantxa","family":"Gonz\u00e1lez-Saitz","sequence":"first","affiliation":[{"name":"Department of Internal Medicine I, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Kaser","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Medical University of Innsbruck","place":["Innsbruck, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"B1","unstructured":"Who launches global guidelines on diabetes during pregnancy on World Diabetes Day\n          \n          \n          Geneva\n          World Health Organization\n          World Health Organization\n          \n          2025"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0098-8","article-title":"Gestational diabetes mellitus","volume":"393","author":"McIntyre","year":"2019","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113342","article-title":"The pathophysiology of gestational diabetes mellitus","volume":"19","author":"Plows","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/01.aoa.0000370496.77221.05","article-title":"Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis","volume":"373","author":"Bellamy","year":"2009","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.29.03.06.dc05-1118","article-title":"Gestational diabetes identifies women at risk for permanent type 1 and type 2 diabetes in fertile age: predictive role of autoantibodies","volume":"29","author":"J\u00e4rvel\u00e4","year":"2006","journal-title":"Diabetes Care"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1663643","article-title":"Autoimmune pathogenesis of gestational diabetes mellitus: the risk of progression to type 1 diabetes mellitus","volume":"16","author":"Skibi\u0144ska","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1055\/a-1744-2856","article-title":"Auto-Antik\u00f6rper-Diagnostik in der Diabetologie \u2013 aktueller Stand der Analytik und klinische Anwendung in Deutschland","volume":"17","author":"Thaler","year":"2022","journal-title":"Diabetol Stoffwechs"},{"key":"B8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11892-016-0738-2","article-title":"Islet autoantibodies","volume":"16","author":"Lampasona","year":"2016","journal-title":"Curr Diabetes Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2009.04.004","article-title":"Diabetes related autoimmunity in gestational diabetes mellitus: is it important","volume":"98","author":"Lapolla","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"B10","article-title":"Progression to type 1 diabetes after gestational diabetes: a longitudinal study","volume":"55","author":"K\u00e4ckenhoff","year":"2018","journal-title":"Acta Diabetol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-05047-w","article-title":"The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening","volume":"63","author":"Jacobsen","year":"2020","journal-title":"Diabetologia"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa624","article-title":"Dynamics of islet autoantibodies during prospective follow-up from birth to age 15 years","volume":"105","author":"P\u00f6ll\u00e4nen","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-1731","article-title":"Autoantibody reversion: changing risk categories in multiple-autoantibody-positive individuals","volume":"43","author":"So","year":"2020","journal-title":"Diabetes Care"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00260","article-title":"Islet autoantibody patterns in patients with type 2 diabetes aged 60 and higher: a cross-sectional study in a Chinese hospital","volume":"9","author":"Li","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.18.12.1557","article-title":"GAD antibodies in NIDDM: ten-year follow-up from the diagnosis","volume":"18","author":"Niskanen","year":"1995","journal-title":"Diabetes Care"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1527","article-title":"Identification of unique antigenic determinants in the amino terminus of IA-2 (ICA512) in childhood and adult autoimmune diabetes: new biomarker development","volume":"40","author":"Acevedo-Calado","year":"2017","journal-title":"Diabetes Care"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2337\/dci24-0042","article-title":"Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes","volume":"47","author":"Moshe","year":"2024","journal-title":"Diabetes Care"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.13.5.478","article-title":"Incidence and significance of islet cell antibodies in women with previous gestational diabetes","volume":"13","author":"Catalano","year":"1990","journal-title":"Diabetes Care"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/BF00403287","article-title":"Gestational diabetes mellitus: evidence for autoimmunity against the pancreatic beta cells","volume":"34","author":"McEvoy","year":"1991","journal-title":"Diabetologia"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s001250050578","article-title":"GAD65 autoantibodies in women with gestational or insulin-dependent diabetes mellitus diagnosed during pregnancy","volume":"39","author":"Petersen","year":"1996","journal-title":"Diabetologia"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2002.tb02987.x","article-title":"Women diagnosed with gestational diabetes mellitus do not carry antibodies against minor islet cell antigens","volume":"958","author":"Balaji","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-6-24","article-title":"Autoimmunity in gestational diabetes mellitus in Sardinia: a preliminary case-control study","volume":"6","author":"Murgia","year":"2008","journal-title":"Reprod Biol Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2011.10.037","article-title":"HLA-DQB1 genotypes and islet cell autoantibodies against GAD65 and IA-2 in relation to development of diabetes postpartum in women with gestational diabetes mellitus","volume":"95","author":"Papadopoulou","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-018-0830-3","article-title":"Presence of diabetes-specific autoimmunity in women with gestational diabetes mellitus predicts impaired glucose regulation at follow-up","volume":"41","author":"Cossu","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1286375","article-title":"Autoantibodies predict type 1 diabetes after gestational diabetes: a 23-year cohort study","volume":"14","author":"Luiro","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1995.tb00414.x","article-title":"Islet cell antibodies and beta-cell function in gestational diabetic women: comparison to first-degree relatives of type 1 (insulin-dependent) diabetic subjects","volume":"12","author":"Mauricio","year":"1995","journal-title":"Diabetes Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)90650-9","article-title":"Prevalence of antibodies to glutamic acid decarboxylase in women who have had gestational diabetes","volume":"173","author":"Beischer","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.46.9.1459","article-title":"Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter study","volume":"46","author":"Fuchtenbusch","year":"1997","journal-title":"Diabetes"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2001.112394","article-title":"Postpartum metabolism and autoantibody markers in women with gestational diabetes mellitus diagnosed in early pregnancy","volume":"184","author":"Bartha","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2001.00180.x","article-title":"Prevalence and features of pancreatic islet cell autoimmunity in women with gestational diabetes from different ethnic groups","volume":"108","author":"Kousta","year":"2001","journal-title":"BJOG"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.55.03.06.db05-0746","article-title":"Predictors of postpartum diabetes in women with gestational diabetes mellitus","volume":"55","author":"L\u00f6bner","year":"2006","journal-title":"Diabetes"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0157","article-title":"Presence of GAD antibodies during gestational diabetes mellitus predicts type 1 diabetes","volume":"30","author":"Nilsson","year":"2007","journal-title":"Diabetes Care"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.963","article-title":"The prevalence of GAD antibodies in Korean women with gestational diabetes mellitus and their clinical characteristics during and after pregnancy","volume":"25","author":"Yu","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2012.03766.x","article-title":"Prevalence of zinc transporter 8 antibodies in gestational diabetes mellitus","volume":"29","author":"Dereke","year":"2012","journal-title":"Diabetes Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/dme.12615","article-title":"Glutamic acid decarboxylase autoantibody positivity postpartum is associated with impaired \u03b2-cell function in women with gestational diabetes mellitus","volume":"32","author":"Lundberg","year":"2015","journal-title":"Diabetes Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2015.11.001","article-title":"IgG4 subclass glutamic acid decarboxylase antibodies are associated with a reduced risk of developing type 1 diabetes and increased C-peptide levels in GADA-positive gestational diabetes","volume":"162","author":"Dereke","year":"2016","journal-title":"Clin Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.973820","article-title":"Type 1 diabetes-related autoimmune antibodies in women with gestational diabetes mellitus and the long-term risk for glucose intolerance","volume":"13","author":"Beunen","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2011.03359.x","article-title":"Gestational diabetes mellitus is associated with TCF7L2 gene polymorphisms independent of HLA-DQB1*0602 genotypes and islet cell autoantibodies","volume":"28","author":"Papadopoulou","year":"2011","journal-title":"Diabetes Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2002.tb02983.x","article-title":"Low frequency of autoantibodies to islet cell, glutamic acid decarboxylase, and second-islet antigen in patients with gestational diabetes mellitus: a follow-up study","volume":"958","author":"Lapolla","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(25)00260-8","article-title":"Managing adults with screen-detected islet autoantibody positivity: a pragmatic framework","volume":"13","author":"Thomas","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1361","article-title":"Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis","volume":"369","author":"Vounzoulaki","year":"2020","journal-title":"BMJ"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108625","article-title":"The absolute and relative risk of type 2 diabetes after gestational diabetes: a systematic review and meta-analysis of 129 studies","volume":"171","author":"Dennison","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(97)00145-2","article-title":"Time-resolved fluorescence imaging in islet cell autoantibody quantitation","volume":"208","author":"Rulli","year":"1997","journal-title":"J Immunol Methods"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1375.035","article-title":"Time-resolved fluorescence imaging of islet cell autoantibodies","volume":"1079","author":"Vuorinen","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2337\/db24-0814","article-title":"Comparative analysis of the sensitivity, specificity, concordance, and 5-year predictive power of diabetes-related autoantibody assays","volume":"74","author":"Krischer","year":"2025","journal-title":"Diabetes"},{"key":"B46","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s43856-024-00478-y","article-title":"Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review","volume":"4","author":"Felton","year":"2024","journal-title":"Commun Med (Lond)"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.5.1293","article-title":"Islet cell autoimmunity in a triethnic adult population of the Third National Health and Nutrition Examination Survey","volume":"53","author":"Barinas-Mitchell","year":"2004","journal-title":"Diabetes"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-05016-3","article-title":"Autoimmunity plays a role in the onset of diabetes after 40 years of age","volume":"63","author":"Rolandsson","year":"2020","journal-title":"Diabetologia"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1848","article-title":"International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-S002","article-title":"Classification and diagnosis of diabetes: Standards of medical care in diabetes\u20142018","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1656833","article-title":"Type 1 diabetes diagnosed during pregnancy\u2014an unusual but important challenge: a case series and review of the literature","volume":"12","author":"Caretto","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S002","article-title":"Diagnosis and classification of diabetes: Standards of care in diabetes\u20142025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.suppl_2.s52","article-title":"Autoantibodies in diabetes","volume":"54","author":"Pihoker","year":"2005","journal-title":"Diabetes"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4308-1","article-title":"Early prediction of autoimmune (type 1) diabetes","volume":"60","author":"Regnell","year":"2017","journal-title":"Diabetologia"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13648","article-title":"Possible heterogeneity of initial pancreatic islet beta-cell autoimmunity heralding type 1 diabetes","volume":"294","author":"Lernmark","year":"2023","journal-title":"J Intern Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00223-4","article-title":"Type 1 diabetes","volume":"401","author":"Quattrin","year":"2023","journal-title":"Lancet"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.yhbeh.2012.02.023","article-title":"Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis","volume":"62","author":"Robinson","year":"2012","journal-title":"Horm Behav"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00265","article-title":"Autoimmune disease in women: endocrine transition and risk across the lifespan","volume":"10","author":"Desai","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1478465","article-title":"Pregnancy-induced displacement of preexisting microchimeric cells in the absence of maternal B and T cells","volume":"15","author":"Pham","year":"2024","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.2.705","article-title":"Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum","volume":"93","author":"Bianchi","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"B61","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00125-023-05877-9","article-title":"Islet autoantibody standardization program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops","volume":"66","author":"Marzinotto","year":"2023","journal-title":"Diabetologia"}],"updated-by":[{"DOI":"10.3389\/fendo.2026.1964758","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000}}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1874930\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:29:00Z","timestamp":1787567340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1874930\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":61,"alternative-id":["10.3389\/fendo.2026.1874930"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1874930","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2026.1874930.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2026.1874930.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fendo.2026.1874930.s003","asserted-by":"subject"}]},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"article-number":"1874930"}}